Clinical Research
Certara Teams Up with Korea Institute of Toxicology for FDA-Ready SEND Dataset
Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certar...
August 04, 2023 | News
MANA Develops Novel "Drycell" Microdroplets to Make Handling Single Cell Easier
To analyze individual cells, the desired number of cells must be isolated spatially. This often requires extensive training and use of expensive laboratory...
August 04, 2023 | News
Peter Mac launches BindiMaps to help patients and visitors with vision impairments
The newly-installed service functions like Google Maps, but has been specifically developed to work indoors with a 10 to 20 times higher accuracy than GPS ...
August 03, 2023 | News
NMPA and FDA Approve First-in-Human Trial for LBL-034 in Multiple Myeloma
This is a first-in-human, single-arm, multicenter, open-label, dose-escalation and expansion clinical study, and plans to enroll patients with relapsed/ref...
August 01, 2023 | News
Daewoong Pharmaceutical Seeks Approval for Fexuprazan in China's Anti-Ulcer Drug Market
Daewoong Pharmaceutical's domestically produced drug no. 34 Fexuprazan, a newly developed one for the treatment of gastroesophageal reflux disease (GERD), ...
July 31, 2023 | News
Transcenta's Anti-sclerostin Antibody TST002 Approved for Phase II Trial in China for Reduced Bone Density Patients
This study aims to evaluate the safety, tolerability, and pharmacokinetics of TST002(Blosozumab) after single and multiple intravenous administrations in p...
July 31, 2023 | News
MSD and Moderna Launch Phase 3 Study for Melanoma Treatment
“As we continue our efforts to advance novel treatment options for patients with high-risk Stage IIB-IV melanoma, the initiation of the V940-001 Phas...
July 28, 2023 | News
AI Medical Service Inc. Signs Joint Research Agreement with Stanford Medicine
AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research...
July 28, 2023 | News
GC Genome Enables Prognosis Prediction and Targeted Treatment in Breast Cancer
''We can gain vital insights into patient prognosis and make informed decisions regarding the most effective treatment strategies through ctDNA CNA...
July 27, 2023 | News
Hummingbird Bioscience Advances HMBD-001 Phase IB Trials in Australia, Partners with Omico for Faster Clinical Development
Hummingbird Bioscience has initiated two clinical trials in Australia evaluating HMBD-001 in patients with squamous non-small cell lung ca...
July 27, 2023 | News
BioMap unveils a “Life Science Leaderboard” to compare AI models
Highlights: New AI leaderboard provides comparison of 25+ of the most important, representative and cutting-edge tasks across six distinct...
July 26, 2023 | News
HaemaLogiX, Peter MacCallum Cancer Centre Announce Myeloma CAR-T Trial Agreement
HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's ...
July 26, 2023 | News
Project Matty to Revolutionize Care for Children with Autism and ADHD Through AI
The co-founders' personal journeys fuel their resolve to bridge the gap in traditional treatments. Born out of one mother's determination to help her ADHD-...
July 25, 2023 | News
RenovoRx and Imugene Join Forces for Oncolytic Virus Therapy Using TAMP Platform
Collaboration will explore trans-arterial delivery of Imugene's CF33 oncolytic virus utilizing RenovoRx's TAMP therapy platform TAMP enables localized, ...
July 25, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
